Outlook Therapeutics, Inc. — Form D

Outlook Therapeutics, Inc. of ISELIN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-07. The offering totals $5.0M. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (45)

Showing 25 of 45 people.

NameRoleLocation
Gerd AuffarthRelated PersonIselin, NJ
Julian GangolliRelated PersonIselin, NJ
Yezan HaddadinRelated PersonIselin, NJ
Kurt J. HilzingerRelated PersonIselin, NJ
Andong HuangRelated PersonIselin, NJ
Lawrence A. KenyonRelated PersonIselin, NJ
Faisal G. SukhtianRelated PersonIselin, NJ
Randy H. ThurmanRelated PersonIselin, NJ
Lawrence A KenyonDirectorIselin, NJ
Lawrence A KenyonExecutive OfficerIselin, NJ
Jeff A EvansonExecutive OfficerIselin, NJ
Faisal G SukhtianDirectorIselin, NJ
Julia A HallerDirectorIselin, NJ
Gerd G AuffarthDirectorIselin, NJ
Yezan H HaddadinDirectorIselin, NJ
Randy H ThurmanDirectorIselin, NJ
Julian G GangolliDirectorIselin, NJ
Andong G HuangDirectorIselin, NJ
Kurt J HilzingerDirectorIselin, NJ
Pankaj MohanDirectorPrinceton, NJ
Pankaj MohanExecutive OfficerPrinceton, NJ
Jeff Russell EvansonExecutive OfficerIselin, NJ
C. Russell TrenaryDirectorIselin, NJ
C. Russell TrenaryExecutive OfficerIselin, NJ
Todd BradyDirectorAtlanta, GA

Other filings by this issuer (12)

FiledFormOfferingSold
2025-01-27D$32.0M
2024-04-16D$13.3M$5.0M
2024-03-29D$159.0M$60.0M
2023-01-06D$1.0M$1.0M
2023-01-06D$31.8M$31.8M
2021-02-12D$4.0M$4.0M
2020-06-09D$16.0M$16.0M
2020-03-11D$8.0M$8.0M
2017-09-25D$40.1M$3.3M
2015-12-23D$50.0M$6.3M
2015-10-13D$14.5M$14.5M
2015-08-10D$31.1M$31.1M

More